|Articles|July 1, 2015
Working with CMOs and CDMOs
Jim Miller, President of PharmSource, spoke with BioPharm International about working with CMOs and CDMOs.
Advertisement
Jim Miller, President of PharmSource, spoke with BioPharm International about how small or mid-size pharma companies can get the attention of top-level CMOs.
Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on BioPharm International
1
Launch in Lockstep: Biopharma Readiness for the CNPV’s Accelerated Clock
2
How Miniaturized Analytics Are Transforming Aseptic Bioprocessing Control
3
How Programmable Biology Could Reshape Biologic Drug Development
4
Ask the Expert: Audits, Inspections, and CDMOs
5
